JP2003512348A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512348A5
JP2003512348A5 JP2001531783A JP2001531783A JP2003512348A5 JP 2003512348 A5 JP2003512348 A5 JP 2003512348A5 JP 2001531783 A JP2001531783 A JP 2001531783A JP 2001531783 A JP2001531783 A JP 2001531783A JP 2003512348 A5 JP2003512348 A5 JP 2003512348A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001531783A
Other languages
Japanese (ja)
Other versions
JP3632191B2 (ja
JP2003512348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/028687 external-priority patent/WO2001028978A1/en
Publication of JP2003512348A publication Critical patent/JP2003512348A/ja
Application granted granted Critical
Publication of JP3632191B2 publication Critical patent/JP3632191B2/ja
Publication of JP2003512348A5 publication Critical patent/JP2003512348A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001531783A 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸 Expired - Fee Related JP3632191B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16072599P 1999-10-20 1999-10-20
US60/160,725 1999-10-20
PCT/US2000/028687 WO2001028978A1 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004266488A Division JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Publications (3)

Publication Number Publication Date
JP2003512348A JP2003512348A (ja) 2003-04-02
JP3632191B2 JP3632191B2 (ja) 2005-03-23
JP2003512348A5 true JP2003512348A5 (enExample) 2005-12-22

Family

ID=22578159

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001531783A Expired - Fee Related JP3632191B2 (ja) 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸
JP2004266488A Expired - Fee Related JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004266488A Expired - Fee Related JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Country Status (50)

Country Link
US (2) US6689906B1 (enExample)
EP (2) EP1226110B1 (enExample)
JP (2) JP3632191B2 (enExample)
KR (2) KR100566462B1 (enExample)
CN (1) CN1165518C (enExample)
AP (2) AP2002002517A0 (enExample)
AR (2) AR026087A1 (enExample)
AT (2) ATE293590T1 (enExample)
AU (2) AU778871B2 (enExample)
BG (2) BG106719A (enExample)
BR (1) BR0014972B1 (enExample)
CA (1) CA2386297C (enExample)
CO (1) CO5280060A1 (enExample)
CR (1) CR6620A (enExample)
CU (1) CU23112A3 (enExample)
CZ (1) CZ295960B6 (enExample)
DE (2) DE60019628T2 (enExample)
DO (1) DOP2000000083A (enExample)
DZ (1) DZ3197A1 (enExample)
EA (1) EA005206B1 (enExample)
EC (1) ECSP045393A (enExample)
EE (1) EE200200211A (enExample)
ES (2) ES2237464T3 (enExample)
GE (1) GEP20043297B (enExample)
GT (2) GT200000183AA (enExample)
HK (1) HK1049826B (enExample)
HN (1) HN2000000224A (enExample)
HR (2) HRP20040709A2 (enExample)
HU (1) HUP0203325A3 (enExample)
IL (3) IL164060A0 (enExample)
IS (2) IS6348A (enExample)
MA (1) MA26842A1 (enExample)
MX (1) MXPA02003229A (enExample)
MY (1) MY127678A (enExample)
NO (2) NO20021780D0 (enExample)
NZ (1) NZ517961A (enExample)
OA (1) OA12070A (enExample)
PA (1) PA8505201A1 (enExample)
PE (1) PE20010740A1 (enExample)
PL (1) PL354607A1 (enExample)
PT (1) PT1226110E (enExample)
SI (1) SI1226110T1 (enExample)
SK (1) SK5232002A3 (enExample)
SV (1) SV2001000188A (enExample)
TR (2) TR200500221T2 (enExample)
TW (2) TWI225855B (enExample)
UA (1) UA72931C2 (enExample)
WO (1) WO2001028978A1 (enExample)
YU (2) YU73004A (enExample)
ZA (1) ZA200202543B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
EP1296671B1 (en) * 2000-06-26 2008-03-26 Warner-Lambert Company LLC Gabapentin analogues for sleep disorders
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
EP1226820A1 (en) * 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
CA2444053C (en) * 2001-04-19 2008-06-17 Warner-Lambert Company Llc Fused bicyclic or tricyclic amino acids
GB2375108A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Production of a bicycloheptanone
GB2375109A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Process for preparing bicyclic amino acid
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
DK1404324T4 (da) * 2001-06-11 2011-07-11 Xenoport Inc Prolægemidler af GABA analoger, sammensætninger og anvendelser deraf
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
KR20040081478A (ko) 2002-01-31 2004-09-21 워너-램버트 캄파니 엘엘씨 이명을 치료하기 위한 알파 2 델타 리간드
JP2005523281A (ja) * 2002-02-22 2005-08-04 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー アルファ−2−デルタリガンドとシクロオキシゲナーゼ−2の選択的阻害剤との組合せ
CA2488566A1 (en) * 2002-06-27 2004-01-08 Warner-Lambert Company Llc Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
JP2005539092A (ja) * 2002-08-15 2005-12-22 ファイザー・インク 縮合二環式または三環式アミノ酸の治療における使用
US7419981B2 (en) 2002-08-15 2008-09-02 Pfizer Inc. Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
AU2003297927A1 (en) 2002-12-11 2004-06-30 Xenoport, Inc. Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
EP2172197A1 (en) 2002-12-13 2010-04-07 Warner-Lambert Company LLC Octanoic acid derivative to treat fibromyalgia and other pains
PL377657A1 (pl) 2002-12-13 2006-02-06 Warner-Lambert Company Llc Ligand Ó-2-Ű do leczenia dolegliwości dolnych dróg moczowych
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
WO2005025675A1 (en) 2003-09-12 2005-03-24 Pfizer Limited Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
MX2009006575A (es) 2006-12-22 2009-07-02 Recordati Ireland Ltd Terapia de combinacion de trastornos del tracto urinario inferior con ligandos a2d y farmacos anti-inflamatorios no esteroidales (nsaids).
ES2531324T3 (es) 2007-09-28 2015-03-13 Daiichi Sankyo Co Ltd Intermedio para producir un derivado de gamma-aminoácido bicíclico
EP2412700B1 (en) 2009-03-26 2016-11-09 Daiichi Sankyo Company, Limited Method for producing bicyclic gamma-amino acid derivative
BR112013031365B1 (pt) 2011-06-08 2021-09-28 Daiichi Sankyo Company, Limited Método para produzir um composto
ES2659162T3 (es) 2011-06-08 2018-03-14 Daiichi Sankyo Company, Limited Procedimiento de producción de compuesto bicíclico a través de una sal de iminio
CN103987687B (zh) 2011-12-15 2015-12-02 第一三共株式会社 使用不对称催化剂的双环化合物的光学拆分方法
BR112014025158B1 (pt) 2012-04-10 2021-09-21 Daiichi Sankyo Company, Limited Método para produzir um composto
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ-胺基酸衍生物及其製造方法
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) * 2021-03-29 2021-06-29 华东理工大学 一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641129A (en) 1969-06-17 1972-02-08 Merck & Co Inc Antifibrinolytic compounds
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
BR9813284B1 (pt) 1997-10-27 2012-08-21 aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.

Similar Documents

Publication Publication Date Title
BE2016C059I2 (enExample)
BE2014C009I2 (enExample)
BE2012C026I2 (enExample)
JP2003500738A5 (enExample)
BE2011C032I2 (enExample)
BE2010C018I2 (enExample)
BRPI0112928B8 (enExample)
JP2003509681A5 (enExample)
JP2000291410A5 (enExample)
BRPI0110940B8 (enExample)
BE2010C040I2 (enExample)
JP2004506252A5 (enExample)
JP2000332717A5 (enExample)
BE2014C025I2 (enExample)
BRPI0113372A8 (enExample)
JP2003510994A5 (enExample)
JP2001236652A5 (enExample)
JP2002055374A5 (enExample)
JP2001224227A5 (enExample)
JP2001281591A5 (enExample)
IN192483B (enExample)
BRPI0000763B8 (enExample)
AM949A2 (enExample)
CN3145763S (enExample)
AU2000270757A8 (enExample)